QUILLICHEW Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Quillichew, and what generic alternatives are available?
Quillichew is a drug marketed by Nextwave Pharms and is included in one NDA. There are ten patents protecting this drug.
The generic ingredient in QUILLICHEW is methylphenidate hydrochloride. There are thirty-two drug master file entries for this compound. Forty-two suppliers are listed for this compound. Additional details are available on the methylphenidate hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Quillichew
A generic version of QUILLICHEW was approved as methylphenidate hydrochloride by SPECGX LLC on November 27th, 1998.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for QUILLICHEW?
- What are the global sales for QUILLICHEW?
- What is Average Wholesale Price for QUILLICHEW?
Summary for QUILLICHEW
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Prices: | Drug price information for QUILLICHEW |
| DailyMed Link: | QUILLICHEW at DailyMed |


